Seres Therapeutics, Inc. (NASDAQ:MCRB) Q2 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. At this time, I would like to welcome everyone to Seres Therapeutics Second Quarter 2024 Earnings Conference Call.
Seres Therapeutics Inc. (MCRB)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Tang Capital Management Kevin C. Tang | 2,407,112 | $1,742,268 | +166% | 0.17% |
| 2. | Millennium Management Israel Englander | 1,777,601 | $1,286,628 | +73% | 0% |
| 3. | Hudson Bay Capital Management Sander Gerber | 1,004,978 | $727,403 | -82% | 0% |
| 4. | Eversept Partners Kamran Moghtaderi | 418,208 | $302,699 | -70% | 0.02% |
| 5. | Lion Point Didric Cederholm | 340,761 | $246,643 | 0.44% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.15 | 5,825,495 | Large Shareholder | 5,825,495 | 2022-07-05 | Filing | |
| $3.15 | 2,912,748 | Large Shareholder | 5,875,711 | 2022-07-05 | Filing | |
| $2.25 | 4,444,444 | Large Shareholder, Director | 4,444,444 | 2019-06-18 | Filing | |
| $2.25 | 4,444,444 | Large Shareholder, Director | 4,444,444 | 2019-06-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.84 | 873 | 124,173 | 2024-08-16 | Filing | ||
| $0.84 | 973 | 21,013 | 2024-08-16 | Filing | ||
| $0.84 | 923 | 67,247 | 2024-08-16 | Filing | ||
| $0.84 | 2,518 | 145,993 | 2024-08-16 | Filing | ||
| $0.84 | 728 | 80,106 | 2024-08-16 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 23,117,045 | $32,434,165 | 2.44% | |
| 2. | 19,388,580 | $27,144,012 | 0% | |
| 3. | 7,339,454 | $10,275,237 | 0% | |
| 4. | 6,005,307 | $8,407,429 | 0% | |
| 5. | 2,362,449 | $3,307,429 | 0% |
News See All
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q1 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Alex, and I will be your conference operator today.
11 Oversold NASDAQ Stocks To Buy Right Now
In this article, we will be taking a look at 11 oversold NASDAQ stocks to buy right now.
11 Oversold Healthcare Stocks To Buy Right Now
In this article, we will be taking a look at 11 oversold healthcare stocks to buy right now.
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q4 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, good morning. My name is Abby, and will be your conference operator today.
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q3 2023 Earnings Call Transcript
Operator: Welcome to the Seres Therapeutics Third Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please note, this event is being recorded.
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q2 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. My name is Desiree, and I will be your conference operator today.
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q4 2022 Earnings Call Transcript
Operator: Thank you for holding, and welcome everyone, to the Seres Therapeutics Fourth Quarter 2022 Conference Call. . Thank you. I will now turn the call over to Dr.
Cathie Wood's Top 15 Small-Cap Stock Picks
In this article, we discuss Cathie Wood’s top 15 small-cap stock picks.
Hedge Funds Have Never Been This Bullish On Seres Therapeutics Inc (MCRB)
We at Insider Monkey have gone over 866 13F filings that hedge funds and prominent investors are required to file by the SEC.
Billionaire Hedge Funds
